Doxazosin
NDC 59762-2420, doxazosin, tablet, from Mylan Pharmaceuticals Inc..
- Product NDC
- 59762-2420
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA019668
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59762-2420 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXAZOSIN MESYLATE2 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59762-2420-7 | 59762242007 | 100 TABLET in 1 BOTTLE (59762-2420-7) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6b887aa5-5edf-48c5-a480-dea8c35afa9dNADAC price for package 59762242007
GET /v1/drugs/nadac/59762242007
Use it
Look up 59762-2420 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59762-2420 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59762-2420. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.